ProShares UltraShort NASDAQ Biotechnology
12 hedge funds and large institutions have $3.34M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
12
Holders Change
+4
Holders Change %
+50%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
–
Calls
$1.29M
Puts
–
Net Calls
+$1.29M
Net Calls Change
+$1.29M
Top Buyers
Top Sellers
1 |
WP
1
WealthSource Partners
San Luis Obispo,
California
|
$212K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$769K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$7K |